Squamous cell carcinoma of head and neck
Not recruitingStudy of Pucotenlimab with Becotatug Vedotin versus Becotatug Vedotin alone for patients with locally advanced head and neck squamous cell carcinoma
Study of Pucotenlimab with Becotatug Vedotin versus Becotatug Vedotin alone for patients with locally advanced head and neck squamous cell carcinoma
- Disease:Squamous cell carcinoma of head and neck
- Substances:PUCOTENLIMAB
France- Participants:18–64 years · 65+ years
- Substances:PUCOTENLIMAB
- Sponsor:Groupe Oncologie Radiotherapie Tete Cou







